CRISPR base editing is a potentially powerful technology that enables the creation of genetic mutations with single base pair resolution. By re-engineering both DNA and protein sequences, we developed a collection of constitutive and inducible base editing vector systems that dramatically improve the ease and efficiency by which single nucleotide variants can be created. This new toolkit is effective in a wide range of model systems, and provides a means for efficient in vivo somatic base editing.
PAM specificity Cas9 variants 13 , which share the same Cas9 cDNA as BE3. In each case, this was corrected by re-engineering the construct with an optimized coding sequence (Figure 1g, Supplementary Figure 5 ) 11 .
Importantly, the resulting increased expression of the HF1 enzyme (HF1 RA ) dramatically improved on-target DNA cleavage, while maintaining little or no off-target activity (Figure 1h ).
The addition of nuclear localization signal (NLS) sequences to the N-terminus of Cas9 can improve the efficiency of gene targeting 14 . Indeed, despite the presence of a C-terminal NLS (Figure 2a) , RA protein was largely excluded from the nucleus in transduced 3T3 cells (Figure 2b) . We tested two different N-terminal positions for the NLS in case the inclusion of these sequences in one location interfered with APOBEC function:
1) with a FLAG epitope tag at the N-terminus ("FNLS"), and 2) within the XTEN linker that bridges APOBEC and Cas9n ("2X") ( Figure 2b ). While 2X showed no obvious increase in nuclear targeting compared to RA, FNLS protein was more evenly distributed through the nucleus and cytoplasm of the cell (Figure 2b ).
In transfection-based assays, FNLS increased editing across multiple target positions and sgRNAs To provide a more flexible and controlled system for base editing, we generated lentiviral constructs whereby BE3, RA, or FNLS expression was controlled by a tetracycline responsive element (TRE 3G ) and doxycycline Together, these data demonstrate that our re-engineered enzymes increase the range (2X) and efficiency (FNLS) of targeted base editing, and enable the effective use of dox-inducible systems to control the timing and duration of base editing. To demonstrate the utility and impact of the improved editors, we set out to engineer a series of To first assess functional editing potential in human cancer cells, we generated DLD1 cells expressing each BE3
variant (Figure 3a) . DLD1 cells are sensitive to combined inhibition of Tankyrase and MEK 15, 16 but activating mutations in CTNNB1 are predicted to induce resistance to this treatment 17 . We introduced sgRNAs targeting codon (Serine) 45 of CTNNB1, or FANCF.S1 as a neutral control (Figure 3b) , and cultured the cells in Tankyrase Figure 9) , FNLS significantly increased the ratio of desired (C>T) to non-desired (C>A, C>G) editing, and decreased the frequency of indels over the target site for both CTNNB1.S45 and FANCF.S1
(Supplementary Figure 12) .
We next tested the ability of the optimized base editing tools to engineer cancer-associated mutations in wildtype intestinal organoids. Nonsense truncating Apc mutations are the most common genetic lesions observed in human colorectal cancers 18 , and drive WNT/RSPO ligand-independent activation of WNT signaling. To recreate this mutation, we co-transfected intestinal organoids with either BE3 or FNLS, and the Apc.1405 sgRNA (Figure 3d) . Strikingly, FNLS-transfected cultures showed a 10-fold increase in outgrowth of RSPO1-independent organoids, relative to BE3-transfected cells (Figure 3d,e) . As expected, they carried a high frequency of targeted Apc disruption (>98%), and the vast majority of these alterations (>97%) were target C>T conversions, with fewer than 1% indels (Figure 3f) . Further, the high editing efficiency of FNLS enabled multiplexed editing of independent genomic loci. Transfection of two tandem arrayed sgRNAs (Apc.1405 and Pik3ca.545) produced Apc Q1405X / Pik3ca E545K mutant organoids (Figure 3f ) that could survive and expand in the presence of a MEK inhibitor (Trametinib; 25nM) (Supplementary Figure 13) , as has been described for HDRgenerated PIK3CA E545K mutations in human intestinal organoids 19 . Thus, improved base editing tools provide a means to rapidly and precisely engineer multiple clinically relevant genetic lesions.
In human hepatocellular carcinoma (HCC), CTNNB1 mutations are the primary mechanism of WNT-driven tumorigenesis in the liver. To explore the potential of base editors to drive tumor formation in vivo, we introduced BE3 or FNLS, a mouse Ctnnb1.S45 sgRNA, and Myc cDNA to the livers of adult mice, via hydrodynamic transfection (Figure 3g) . After 4 weeks, 3/5 BE3 transfected animals showed 1-2 small tumor nodules on the liver, while FNLS-transfected mice had dramatically increased disease burden with all mice (5/5) carrying multiple tumors (Figure 3g,h) . Histologically, tumors resembled HCCs with trabecular and solid growth pattern, and showed upregulation of the β-catenin target, Glutamine synthetase 20 (GS; Figure 3h ). As expected, tumor nodules showed efficient editing of the target Ctnnb1 locus, to create activating S45F mutations (Figure 3h ).
An alternate approach to in vivo somatic base editing is the generation of temporally regulated transgenic strains, which enables the manipulation of tissues and cell types that cannot be easily transfected in vivo, and avoids the potential immunogenicity of exogenous Cas9 delivery 21, 22 . We generated knock-in transgenic mouse embryonic stem cells (ESCs), in which BE3 or RA expression is controlled by the TRE promoter. We chose RA . Together, these data show that optimized RA and FNLS constructs offer a flexible and efficient platform to engineer directed somatic alterations in animals.
Cas9-mediated base editing is a flexible and precise platform to engineer disease-relevant genetic alleles, and may provide a path forward for CRISPR-based therapeutics. Here, we developed optimized APOBEC-Cas9 fusion enzymes that dramatically improve base editing across multiple model systems and cell types, and offer a means for key for effective in vitro and in vivo base editing. Further, the generation of base editing enzymes that are efficient translated will be critically important for therapeutic approaches that rely on delivery of mRNA molecules 23 . Together, we believe these optimized enzymes make base editing technology a feasible and accessible option for a wide range of research and therapeutic applications. 
pLenti-TRE 3G -BE3-PGK-Puro (L3BP) was generated by Gibson assembly, combining a PCR-amplified TRE3G
promoter (3G_F/3G_R), and APOBEC fragment (APOBEC_F/BE3RA_XTEN_R) with an XmaI digested 24 .
Transfection: For transfection-based editing experiments in HEK293Ts, cells were seeded on a 12-well plate at 80% confluence and co-transfected with 750ng of base editor (BE), 750ng of sgRNA expression plasmid, and 4.5µl of polyethyleminine (PEI; 1mg/ml). Cells were harvested for genomic DNA, 3 days post-transfection. For virus production, HEK293T cells were plated in a 6 well-plate and transfected 12 hours later (95% confluence) with a prepared mix in DMEM media (no supplements) containing 2.5µg of lentiviral backbone, 1.25µg of PAX2, 1.25µg of VSV-G, and 15µl of PEI (1mg/ml). 36hrs following transfection, media was replaced with target cell collection media and supernatants were harvested every 8-12hrs up to 72hrs post transfection. ESCs col1a1-targeting constructs were introduced via nucleofection in 16-well strips, using buffer P3 (Lonza Inc.,
V4XP-3032) in a 4D Nucleofector with X-unit attachment (Lonza Inc.). Two days following nucleofection, cells
were treated with media containing 150ug/ml Hygromycin B and individual surviving clones were picked after 9-10 days of selection. Two days after clones were picked Hygromycin was removed from the media and cells were cultured in M15 thereafter. To confirm integration at the col1a1 locus we used a multiplex col1a1 PCR 24 .
Transduction: 7.5 x 10 4 NIH/3T3 or DLD1 cells were plated on 6-well plate. 24hrs following plating, cells were transduced with viral supernatants in the presence of polybrene (8µg/µl). Two days after transduction cells were selected in Puromycin (2 ug/ml), Blasticidin S (4 µg/ml) or G418 (Neomycin; 500 ug/ml). 500k ESCs were plated in 6-well plates on gelatin and spinocculated (90 mins, 32°C, 2100 rpm) with 150 µl of concentrated lentiviral particles (using 100mg/ml polyethylene glycol, Sigma Aldrich P4338) in 1 ml of media containing polybrene (8µg/µl). After spin, media was replaced. Trametinib every 48h and remaining tdTomato-positive cells were tracked every 5 days by flow cytometry using a BD-Accuri C6 cytometer.
Organoid isolation, culture, transfection, and transduction
Organoid isolation was performed as previously described 25, 26 . Briefly, 15 cm of the proximal small intestine was removed, flushed and washed with cold PBS. The intestine was then cut into 5 mm pieces and placed into 10 ml cold 5mM EDTA-PBS and vigorously resuspended using a 10ml pipette. The supernatant was aspirated and replaced with 10ml EDTA and placed at 4ºC on a benchtop roller for 10 minutes. This was then repeated was then laid on top of the Matrigel.
Maintenance: Media was changed on organoids every two days and they were passaged 1:4 every 5-7 days. To passage, the growth media was removed and the Matrigel was resuspended in cold PBS and transferred to a 15ml falcon tube. The organoids were mechanically disassociated using a p1000 or a p200 pipette and pipetting 50-100 times. 7 ml of cold PBS was added to the tube and pipetted 20 times to fully wash the cells. The cells were then centrifuged at 1000 RPM for 5 minutes and the supernatant was aspirated. They were then resuspended in GFR Matrigel and replated as above. For freezing, after spinning the cells were resuspended in Basal Media containing 10% FBS and 10% DMSO and stored in liquid nitrogen indefinitely.
Transfection: Murine small intestinal organoids were cultured in medium containing CHIR99021 (5µΜ) and Y-27632 (10µΜ) for 2 days prior to transfection. Cells suspensions were produced by dissociating organoids with TrypLE TM express (Invitrogen #12604) for 5 min at 37°C. After trypsinization, cell clusters in 300µl transfection medium were combined with 100µl DMEM/F12-Lipofectamine2000 (Invitrogen #11668)-DNA mixture (97ul-2ul-1ug), and transferred into a 48-well culture plate. The plate was centrifuged at 600g at 32°C for 60 min, followed by another 6h incubation at 37°C. The cell clusters were spun down and plated in Matrigel.
For selecting organoids with Apc mutations, exogenous RSPO1 was withdrawn 2-3 days after transfection. For selection of Pik3ca alterations, organoids were cultured in medium containing Trametinib (25nM) for 1 week.
Transduction: Organoids were prepared as described for transfection to generate small cell clusters. They were then mixed with viral supernatant and polybrene (8µg/µl) before spinocculation and incubation at 37C. Cell clusters were plated as described for transfection and, after 48 hours, organoids were selected with Puromycin (2µg/µl) for 5-7 days (including at least one passage).
Hydrodynamic delivery
All animal experiments were authorized by the regional board Karlsruhe, Germany (animal permit number 
Lentiviral titer assay
Lentiviral titers were calculated using a quantitative PCR-based kit (LV900; Applied Biological Materials Inc.), according to the manufacturer's instructions. Briefly, 2µl of unconcentrated viral supernatant was lysed for 3mins at room temperature, and the crude lysis was used to perform qPCR amplification. The concentration of viral particles was calculated as described in the protocol (http://www.abmgood.com/High-Titer-LentivirusCalculation.html).
Genomic DNA isolation. Cells were lysed in genomic lysis buffer (10 mM Tris pH 7.5, 10 mM EDTA, 0.5% SDS, 400 µg/ml Proteinase K) for at least 2hrs at 55C. Following Proteinase K heat inactivation at 95C for 15 mins, 0.5 volumes of 5M NaCl was added and centrifuged for 10mins at 15K rpm. Supernatant was mixed with 1 volume of isopropanol and DNA precipitates were washed in EtOH 70% before resuspension in 10 mM Tris pH 8.0. 
Puro copy number assay

Immunohistochemistry
Slides containing 3µm thick liver sections were deparaffinized and rehydrated using a descending alcohol series.
For antigen retrieval slides were cooked in sodium-citrate buffer (pH 6.0) in a pressure cooker for 8 minutes.
Subsequently, endogenous HRP was blocked for 10 minutes in 3% H 2 O 2 . Slides were blocked with in PBS containing 5% BSA for one hour before incubation with the primary antibody (Anti-mouse Glutamine Synthetase, BD610517, BD, Heidelberg Germany) overnight (1:200 dilution in PBS/5% BSA). Slides were washed three times and staining was visualized using DAKO Real Detection System (K5003, DAKO, Hamburg, Germany) according to the manufacturers instructions.
PCR amplification for MiSeq
Target genomic regions of interest were amplified by PCR using primers pairs listed in Supplementary oligo 
